Efficacy of secukinumab in pediatric patients with moderate to severe plaque psoriasis: A randomized study
Secukinumab demonstrates therapeutic efficacy and safety in the treatment of moderate to severe plaque psoriasis in pediatric and adolescent patients, suggesting its potential as a treatment option for this population.
Authors
- Xi-Ji Lu
- Ying Zhou (ORCID: https://orcid.org/0000-0002-6147-6753)
- Li Lei (ORCID: https://orcid.org/0000-0001-5429-9675)
- Long Wang (ORCID: https://orcid.org/0000-0002-4905-9885)
- Yuping Zhang (ORCID: https://orcid.org/0000-0002-5494-3747)
- Chen Li (ORCID: https://orcid.org/0009-0004-0645-9776)
- Ni Liang
Institutions
- National Clinical Research Center for Digestive Diseases (CN)
- Zhongshan People's Hospital (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1097/md.0000000000046058
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00